I like the WI April presentation aswell with the company stating -
"deal sizes will go exponential this year based on current deals in negotiation"
When you take into account that the cumulative total of the past 2 deals is $240m+ then the next 3 must be starting to get BIG if going exponential from that point....
and if you take the theory you stated that analysts often get a better quality briefing than market then BioShares April update probably gives a nice little clue, with not only 3 new partnerships but expanded/new agreements with existing partners - which i guess means i'd expect Roche to be followed through by another - AZ ?
I like the WI April presentation aswell with the company stating...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |